CN104145973B - A kind of bactericidal composition containing volution bacterium amine Yu methoxy acrylic - Google Patents
A kind of bactericidal composition containing volution bacterium amine Yu methoxy acrylic Download PDFInfo
- Publication number
- CN104145973B CN104145973B CN201410404431.4A CN201410404431A CN104145973B CN 104145973 B CN104145973 B CN 104145973B CN 201410404431 A CN201410404431 A CN 201410404431A CN 104145973 B CN104145973 B CN 104145973B
- Authority
- CN
- China
- Prior art keywords
- bacterium amine
- volution bacterium
- volution
- kresoxim
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000894006 Bacteria Species 0.000 title claims abstract description 211
- 150000001412 amines Chemical class 0.000 title claims abstract description 201
- 239000000203 mixture Substances 0.000 title claims abstract description 42
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 23
- 239000005869 Pyraclostrobin Substances 0.000 claims abstract description 42
- HZRSNVGNWUDEFX-UHFFFAOYSA-N pyraclostrobin Chemical compound COC(=O)N(OC)C1=CC=CC=C1COC1=NN(C=2C=CC(Cl)=CC=2)C=C1 HZRSNVGNWUDEFX-UHFFFAOYSA-N 0.000 claims abstract description 42
- 201000010099 disease Diseases 0.000 claims abstract description 20
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 20
- 241000221785 Erysiphales Species 0.000 claims abstract description 11
- 241000233679 Peronosporaceae Species 0.000 claims abstract description 9
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 claims abstract description 9
- 241000193738 Bacillus anthracis Species 0.000 claims abstract description 3
- 240000007594 Oryza sativa Species 0.000 claims abstract description 3
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 3
- 206010039509 Scab Diseases 0.000 claims abstract description 3
- 230000035613 defoliation Effects 0.000 claims abstract description 3
- 235000009566 rice Nutrition 0.000 claims abstract description 3
- 239000000839 emulsion Substances 0.000 claims description 43
- 239000000375 suspending agent Substances 0.000 claims description 23
- 239000004530 micro-emulsion Substances 0.000 claims description 22
- 239000000725 suspension Substances 0.000 claims description 19
- 239000000945 filler Substances 0.000 claims description 3
- 239000012752 auxiliary agent Substances 0.000 claims description 2
- 239000000306 component Substances 0.000 claims 1
- 239000005800 Kresoxim-methyl Substances 0.000 abstract description 48
- ZOTBXTZVPHCKPN-HTXNQAPBSA-N kresoxim-methyl Chemical compound CO\N=C(\C(=O)OC)C1=CC=CC=C1COC1=CC=CC=C1C ZOTBXTZVPHCKPN-HTXNQAPBSA-N 0.000 abstract description 48
- -1 ZJ0712 Chemical compound 0.000 abstract description 47
- VMNULHCTRPXWFJ-UJSVPXBISA-N enoxastrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1CO\N=C(/C)\C=C\C1=CC=C(Cl)C=C1 VMNULHCTRPXWFJ-UJSVPXBISA-N 0.000 abstract description 43
- 239000005784 Fluoxastrobin Substances 0.000 abstract description 33
- UFEODZBUAFNAEU-NLRVBDNBSA-N fluoxastrobin Chemical compound C=1C=CC=C(OC=2C(=C(OC=3C(=CC=CC=3)Cl)N=CN=2)F)C=1C(=N/OC)\C1=NOCCO1 UFEODZBUAFNAEU-NLRVBDNBSA-N 0.000 abstract description 33
- 230000000694 effects Effects 0.000 abstract description 15
- 239000000575 pesticide Substances 0.000 abstract description 13
- 230000000855 fungicidal effect Effects 0.000 abstract description 4
- 238000001228 spectrum Methods 0.000 abstract description 3
- 238000003912 environmental pollution Methods 0.000 abstract description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 48
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 46
- 239000003814 drug Substances 0.000 description 38
- 238000013329 compounding Methods 0.000 description 32
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 30
- 239000008367 deionised water Substances 0.000 description 29
- 229910021641 deionized water Inorganic materials 0.000 description 29
- 238000012360 testing method Methods 0.000 description 28
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 27
- 229920002545 silicone oil Polymers 0.000 description 27
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 20
- 229940051841 polyoxyethylene ether Drugs 0.000 description 17
- 229920000056 polyoxyethylene ether Polymers 0.000 description 17
- 230000001018 virulence Effects 0.000 description 13
- 241000209140 Triticum Species 0.000 description 11
- 235000021307 Triticum Nutrition 0.000 description 11
- 239000003795 chemical substances by application Substances 0.000 description 11
- 239000000843 powder Substances 0.000 description 11
- 239000005730 Azoxystrobin Substances 0.000 description 10
- 108010010803 Gelatin Proteins 0.000 description 10
- 239000004372 Polyvinyl alcohol Substances 0.000 description 10
- 210000000481 breast Anatomy 0.000 description 10
- WSFSSNUMVMOOMR-UHFFFAOYSA-N formaldehyde Substances O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 10
- 229920000159 gelatin Polymers 0.000 description 10
- 239000008273 gelatin Substances 0.000 description 10
- 235000019322 gelatine Nutrition 0.000 description 10
- 235000011852 gelatine desserts Nutrition 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 229920002451 polyvinyl alcohol Polymers 0.000 description 10
- 230000003449 preventive effect Effects 0.000 description 10
- 231100000820 toxicity test Toxicity 0.000 description 10
- 239000002202 Polyethylene glycol Substances 0.000 description 9
- 150000002148 esters Chemical group 0.000 description 9
- 229920001223 polyethylene glycol Polymers 0.000 description 9
- 229920001296 polysiloxane Polymers 0.000 description 9
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 8
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 8
- 239000004141 Sodium laurylsulphate Substances 0.000 description 8
- WFDXOXNFNRHQEC-GHRIWEEISA-N azoxystrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1OC1=CC(OC=2C(=CC=CC=2)C#N)=NC=N1 WFDXOXNFNRHQEC-GHRIWEEISA-N 0.000 description 8
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 8
- 230000001988 toxicity Effects 0.000 description 8
- 231100000419 toxicity Toxicity 0.000 description 8
- MHZGKXUYDGKKIU-UHFFFAOYSA-N Decylamine Chemical compound CCCCCCCCCCN MHZGKXUYDGKKIU-UHFFFAOYSA-N 0.000 description 7
- 229910019142 PO4 Inorganic materials 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 7
- 239000010452 phosphate Substances 0.000 description 7
- 239000000230 xanthan gum Substances 0.000 description 7
- 235000010493 xanthan gum Nutrition 0.000 description 7
- 229920001285 xanthan gum Polymers 0.000 description 7
- 229940082509 xanthan gum Drugs 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 239000004359 castor oil Substances 0.000 description 6
- 235000019438 castor oil Nutrition 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 6
- 230000005764 inhibitory process Effects 0.000 description 6
- 229920000136 polysorbate Polymers 0.000 description 6
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 6
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 6
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 6
- 230000002265 prevention Effects 0.000 description 6
- 235000019832 sodium triphosphate Nutrition 0.000 description 6
- 241000255789 Bombyx mori Species 0.000 description 5
- 150000001298 alcohols Chemical class 0.000 description 5
- 150000004996 alkyl benzenes Chemical class 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 239000007859 condensation product Substances 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 238000013401 experimental design Methods 0.000 description 5
- 230000000149 penetrating effect Effects 0.000 description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 5
- 229920005646 polycarboxylate Polymers 0.000 description 5
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 4
- 235000010489 acacia gum Nutrition 0.000 description 4
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 4
- 229940077388 benzenesulfonate Drugs 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000012827 research and development Methods 0.000 description 4
- 238000009736 wetting Methods 0.000 description 4
- DMAXMXPDVWTIRV-UHFFFAOYSA-N 2-(2-phenylethyl)phenol Chemical compound OC1=CC=CC=C1CCC1=CC=CC=C1 DMAXMXPDVWTIRV-UHFFFAOYSA-N 0.000 description 3
- 229920005682 EO-PO block copolymer Polymers 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 230000008485 antagonism Effects 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 244000052616 bacterial pathogen Species 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- LLEMOWNGBBNAJR-UHFFFAOYSA-N biphenyl-2-ol Chemical compound OC1=CC=CC=C1C1=CC=CC=C1 LLEMOWNGBBNAJR-UHFFFAOYSA-N 0.000 description 3
- 150000007942 carboxylates Chemical class 0.000 description 3
- 239000002270 dispersing agent Substances 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- NVVZQXQBYZPMLJ-UHFFFAOYSA-N formaldehyde;naphthalene-1-sulfonic acid Chemical compound O=C.C1=CC=C2C(S(=O)(=O)O)=CC=CC2=C1 NVVZQXQBYZPMLJ-UHFFFAOYSA-N 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- AICOOMRHRUFYCM-ZRRPKQBOSA-N oxazine, 1 Chemical compound C([C@@H]1[C@H](C(C[C@]2(C)[C@@H]([C@H](C)N(C)C)[C@H](O)C[C@]21C)=O)CC1=CC2)C[C@H]1[C@@]1(C)[C@H]2N=C(C(C)C)OC1 AICOOMRHRUFYCM-ZRRPKQBOSA-N 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 239000000080 wetting agent Substances 0.000 description 3
- LYCAIKOWRPUZTN-NMQOAUCRSA-N 1,2-dideuteriooxyethane Chemical compound [2H]OCCO[2H] LYCAIKOWRPUZTN-NMQOAUCRSA-N 0.000 description 2
- NASPPUKURYESFJ-UHFFFAOYSA-N C(C)C1=C(C=CC=C1)O.C1=CC=CC=C1 Chemical compound C(C)C1=C(C=CC=C1)O.C1=CC=CC=C1 NASPPUKURYESFJ-UHFFFAOYSA-N 0.000 description 2
- 240000008067 Cucumis sativus Species 0.000 description 2
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 229920001732 Lignosulfonate Polymers 0.000 description 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 2
- 241000047703 Nonion Species 0.000 description 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 240000003768 Solanum lycopersicum Species 0.000 description 2
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- QYKIQEUNHZKYBP-UHFFFAOYSA-N Vinyl ether Chemical compound C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 125000002877 alkyl aryl group Chemical group 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 230000002528 anti-freeze Effects 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 239000013530 defoamer Substances 0.000 description 2
- 238000002242 deionisation method Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 230000009931 harmful effect Effects 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- 239000001587 sorbitan monostearate Substances 0.000 description 2
- 235000011076 sorbitan monostearate Nutrition 0.000 description 2
- 229940035048 sorbitan monostearate Drugs 0.000 description 2
- PUYXTUJWRLOUCW-UHFFFAOYSA-N spiroxamine Chemical compound O1C(CN(CC)CCC)COC11CCC(C(C)(C)C)CC1 PUYXTUJWRLOUCW-UHFFFAOYSA-N 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- YDIKCZBMBPOGFT-DIONPBRTSA-N (2s,3r,4s,5s,6r)-2-[5,7-dihydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)chromenylium-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol;chloride Chemical compound [Cl-].COC1=C(O)C(OC)=CC(C=2C(=CC=3C(O)=CC(O)=CC=3[O+]=2)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1 YDIKCZBMBPOGFT-DIONPBRTSA-N 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- PQUXFUBNSYCQAL-UHFFFAOYSA-N 1-(2,3-difluorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(F)=C1F PQUXFUBNSYCQAL-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- MREIFUWKYMNYTK-UHFFFAOYSA-N 1H-pyrrole Chemical class C=1C=CNC=1.C=1C=CNC=1 MREIFUWKYMNYTK-UHFFFAOYSA-N 0.000 description 1
- YSUQLAYJZDEMOT-UHFFFAOYSA-N 2-(butoxymethyl)oxirane Chemical compound CCCCOCC1CO1 YSUQLAYJZDEMOT-UHFFFAOYSA-N 0.000 description 1
- CUFXMPWHOWYNSO-UHFFFAOYSA-N 2-[(4-methylphenoxy)methyl]oxirane Chemical compound C1=CC(C)=CC=C1OCC1OC1 CUFXMPWHOWYNSO-UHFFFAOYSA-N 0.000 description 1
- AOBIOSPNXBMOAT-UHFFFAOYSA-N 2-[2-(oxiran-2-ylmethoxy)ethoxymethyl]oxirane Chemical compound C1OC1COCCOCC1CO1 AOBIOSPNXBMOAT-UHFFFAOYSA-N 0.000 description 1
- KXGFMDJXCMQABM-UHFFFAOYSA-N 2-methoxy-6-methylphenol Chemical compound [CH]OC1=CC=CC([CH])=C1O KXGFMDJXCMQABM-UHFFFAOYSA-N 0.000 description 1
- LQAQMOIBXDELJX-UHFFFAOYSA-N 2-methoxyprop-2-enoic acid Chemical compound COC(=C)C(O)=O LQAQMOIBXDELJX-UHFFFAOYSA-N 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- JCUDAMKYTWVICI-UHFFFAOYSA-N 4-benzyl-2,3-dimethylphenol Chemical compound C1=C(O)C(C)=C(C)C(CC=2C=CC=CC=2)=C1 JCUDAMKYTWVICI-UHFFFAOYSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- KHBQMWCZKVMBLN-UHFFFAOYSA-N Benzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC=C1 KHBQMWCZKVMBLN-UHFFFAOYSA-N 0.000 description 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010053759 Growth retardation Diseases 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- IGFHQQFPSIBGKE-UHFFFAOYSA-N Nonylphenol Natural products CCCCCCCCCC1=CC=C(O)C=C1 IGFHQQFPSIBGKE-UHFFFAOYSA-N 0.000 description 1
- PXUQTDZNOHRWLI-JJYSZZJESA-O Oenin Natural products O(C)c1c(O)c(OC)cc(-c2c(O[C@H]3[C@@H](O)[C@H](O)[C@H](O)[C@@H](CO)O3)cc3c(O)cc(O)cc3[o+]2)c1 PXUQTDZNOHRWLI-JJYSZZJESA-O 0.000 description 1
- FQYUMYWMJTYZTK-UHFFFAOYSA-N Phenyl glycidyl ether Chemical compound C1OC1COC1=CC=CC=C1 FQYUMYWMJTYZTK-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 235000004443 Ricinus communis Nutrition 0.000 description 1
- 239000004283 Sodium sorbate Substances 0.000 description 1
- 239000005837 Spiroxamine Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical class OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 229910000004 White lead Inorganic materials 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000012271 agricultural production Methods 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- VEQOALNAAJBPNY-UHFFFAOYSA-N antipyrine Chemical compound CN1C(C)=CC(=O)N1C1=CC=CC=C1 VEQOALNAAJBPNY-UHFFFAOYSA-N 0.000 description 1
- 229960000892 attapulgite Drugs 0.000 description 1
- 150000003851 azoles Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000012216 bentonite Nutrition 0.000 description 1
- ZCILODAAHLISPY-UHFFFAOYSA-N biphenyl ether Natural products C1=C(CC=C)C(O)=CC(OC=2C(=CC(CC=C)=CC=2)O)=C1 ZCILODAAHLISPY-UHFFFAOYSA-N 0.000 description 1
- VJOCYCQXNTWNGC-UHFFFAOYSA-L calcium;benzenesulfonate Chemical compound [Ca+2].[O-]S(=O)(=O)C1=CC=CC=C1.[O-]S(=O)(=O)C1=CC=CC=C1 VJOCYCQXNTWNGC-UHFFFAOYSA-L 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000004495 emulsifiable concentrate Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- SNQQPOLDUKLAAF-UHFFFAOYSA-N nonylphenol Chemical compound CCCCCCCCCC1=CC=CC=C1O SNQQPOLDUKLAAF-UHFFFAOYSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 125000006353 oxyethylene group Chemical group 0.000 description 1
- 229910052625 palygorskite Inorganic materials 0.000 description 1
- 239000005011 phenolic resin Substances 0.000 description 1
- 229920001568 phenolic resin Polymers 0.000 description 1
- 150000003014 phosphoric acid esters Chemical class 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229940088417 precipitated calcium carbonate Drugs 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 150000003217 pyrazoles Chemical class 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229940047670 sodium acrylate Drugs 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- LROWVYNUWKVTCU-STWYSWDKSA-M sodium sorbate Chemical compound [Na+].C\C=C\C=C\C([O-])=O LROWVYNUWKVTCU-STWYSWDKSA-M 0.000 description 1
- 235000019250 sodium sorbate Nutrition 0.000 description 1
- PYODKQIVQIVELM-UHFFFAOYSA-M sodium;2,3-bis(2-methylpropyl)naphthalene-1-sulfonate Chemical compound [Na+].C1=CC=C2C(S([O-])(=O)=O)=C(CC(C)C)C(CC(C)C)=CC2=C1 PYODKQIVQIVELM-UHFFFAOYSA-M 0.000 description 1
- JHJUUEHSAZXEEO-UHFFFAOYSA-M sodium;4-dodecylbenzenesulfonate Chemical compound [Na+].CCCCCCCCCCCCC1=CC=C(S([O-])(=O)=O)C=C1 JHJUUEHSAZXEEO-UHFFFAOYSA-M 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 239000004563 wettable powder Substances 0.000 description 1
Abstract
The invention discloses a kind of bactericidal composition containing volution bacterium amine Yu methoxy acrylic, in compositions, active components A is selected from volution bacterium amine, B is selected from any one antibacterial following: Fluoxastrobin, kresoxim-methyl, ZJ0712, pyraclostrobin, Enestroburin, and the ratio of weight and number of two kinds of active components of A, B is 60:1 to 1:40.Various crop disease can be prevented and treated, and there is obvious potentiation, and expand fungicidal spectrum, the diseases such as downy mildew, epidemic disease, anthrax, powdery mildew, rust, spot defoliation, leaf spot, scab, rice blast are had greater activity；And decrease pesticide usage amount, reduce pesticide residual quantity on crop, alleviate environmental pollution.
Description
The application is divisional application, and original application is the special of Shaanxi Welch Crop Protection Co., Ltd.
Profit application " a kind of bactericidal composition containing volution bacterium amine Yu methoxy acrylic ", former Shen
Application No. 201110105521.X please, original application day is 2011.04.26.
Technical field
The invention belongs to technical field of pesticide, relate to a kind of containing volution bacterium amine and methoxy acrylic acid
The bactericidal composition of esters.
Background technology
Fungus is topmost phytopathogen, and the plant disease of more than 70% is all to be drawn by fungus
Rising, because its paathogenic factor is complicated, difficulty of prevention and cure is the biggest.In recent years, along with rural area plantation knot
The adjustment of structure, planting fruit trees area is continuously increased, the generation journey of many fungal diseases on fruit tree
Degree is consequently increased, and causes huge economic loss.
Volution bacterium amine (Spiroxamine), molecular formula: C18H35NO2, English another name:
N-Ethyl-N-propyl-8-tert-butyl-1,4-dioxaspiro[4.5]dec-2-ylmethylamine。
Volution bacterium amine is substitutional amine-group antibacterial, and sterol biosynthesis inhibitor mainly suppresses pathogenic bacteria
The synthesis of the hydroxymethylated enzyme of C-14.Controlling object is wheat powdery mildew and various rust, greatly
Wheat moire disease and stripe disease.Volution bacterium amine is a kind of novel, page antibacterial of interior absorption, right
Powdery mildew has specially good effect.Speed of action is fast and the lasting period is long, has protection and therapeutical effect concurrently.Both may be used
To be used alone, again can be with other fungicide compoundings to expand fungicidal spectrum.Using dosage
375-750g(a.i.)/hm2。
But, in the real process of agricultural production, the problem that controlling disease is easiest to produce
It it is the drug-fast generation of pathogenic bacteria.Different cultivars composition compounds, and is to prevent and treat resistance pathogenic bacteria very
Common method.Heterogeneity compounds, and according to practical application effect, judges certain
Compounding be potentiation, add and or antagonism.In most cases, the compounding effect of pesticide
Fruit is all additive effect, really has the compounding little of potentiation, and especially potentiation is non-
Compounding that Chang Mingxian, potentiation ratio are the highest is the most less.Studying through inventor, finding will
Volution bacterium amine and Fluoxastrobin, kresoxim-methyl, ZJ0712, pyraclostrobin and Enestroburin are compounding
After can produce good potentiation, and about volution bacterium amine and methoxy acrylic
Compounding being correlated with of compound Fluoxastrobin, kresoxim-methyl, ZJ0712, pyraclostrobin and Enestroburin
Report the openest.
Summary of the invention
A kind of bactericidal composition containing volution bacterium amine Yu methoxy acrylic, including effectively living
Property composition, auxiliary agent and filler, it is characterised in that: A, B ratio of weight and number be 60:1 extremely
1:40, active component A be selected from volution bacterium amine, active component B be Fluoxastrobin, kresoxim-methyl,
ZJ0712, pyraclostrobin, Enestroburin.
Described a kind of bactericidal composition containing volution bacterium amine Yu methoxy acrylic, it is special
Levy and be: the ratio of weight and number of two kinds of active components of A, B is 40:1 to 1:20, preferably
For 20:1 to 1:10.
Described bactericidal composition, it is characterised in that: volution bacterium amine and the parts by weight of Fluoxastrobin
Ratio is 20:1 to 1:10, preferably 10:1 to 1:5.
Described bactericidal composition, it is characterised in that: volution bacterium amine and the parts by weight of kresoxim-methyl
Ratio is 20:1 to 1:10, preferably 10:1 to 1:5.
Described bactericidal composition, it is characterised in that: volution bacterium amine and the weight portion of ZJ0712
Number ratio is 20:1 to 1:10, preferably 10:1 to 1:5.
Described bactericidal composition, it is characterised in that: volution bacterium amine and the weight of pyraclostrobin
Portion rate is 20:1 to 1:10, preferably 10:1 to 1:5.
Described bactericidal composition, it is characterised in that: volution bacterium amine and the weight portion of Enestroburin
Number ratio is 20:1 to 1:10, preferably 10:1 to 1:5.
The ratio of weight and number of two kinds of active components of A, B is 60:1～1:40.Generally compositions
The weight percentage of middle activity is the 0.5～90% of gross weight, is preferably 5%～85%.
According to different preparation types, active component content scope is different.Generally, liquid preparation
Containing by weight 1～70% active substance, preferably 5～50%；Solid preparation contains
By weight 5～the active substance of 85%, preferably 10～80%.
The bactericidal composition of the present invention at least contains a kind of surfactant, when being beneficial to use
Active component dispersion in water.Surface-active contents is the 5～30% of total formulation weight amount,
Surplus is solid or liquid diluent.
Surfactant selected by the bactericidal composition of the present invention is those skilled in the art institutes
Known: one or more in dispersant, wetting agent, binding agent or defoamer can be selected from.
According to different dosage form, preparation can also contain disintegrating agent known in those skilled in the art,
Antifreeze etc..
Described dispersant is selected from alkylnaphthalene sulfonate, the condensation of double (alkyl) naphthalene sulphonate formaldehyde
Thing, naphthalene sulfonic acid-formaldehyde condensation product, aryl phenol polyoxyethylene succinate sulfonate, octylphenol polyethylene
The phonetic first of oxyethylene group ether sulfate, polycarboxylate, lignosulfonates, alkylphenol-polyethenoxy
Aldehyde condensate sulfate, alkyl benzene sulfonate calcium salt, naphthalene sulfonic acid-formaldehyde condensation product sodium salt, alkyl phenol
Polyoxyethylene is phonetic, aliphatic amine polyoxyethylene is phonetic, polyoxyethylene carboxylate, ester polyoxyethylene are phonetic
In one or more.
Described wetting agent is selected from: sodium lauryl sulphate, dodecylbenzene sodium sulfonate, pull open
One or more in powder BX, wetting and penetrating agent F, spaonin powder, Bombyx mori L., Fructus Sapindi Mukouossi powder.
Described disintegrating agent is selected from: one in bentonite, carbamide, ammonium sulfate, aluminum chloride or
Multiple.
Described binding agent is selected from: arabic gum, xanthan gum, sodium tripolyphosphate, phenolic resin,
Sodium alginate, white dextrin, methylcellulose, sodium acrylate, polyvinylpyrrolidone, crosslinking
One or more in polyvinylpyrrolidone, Polyethylene Glycol, polyvinyl alcohol.
Described antifreeze is selected from: in ethylene glycol, propylene glycol, glycerol, Polyethylene Glycol
Plant or multiple.
Described defoamer is selected from: silicone, C8～10Aliphatic alcohols, C10～20Satisfied fatty acid
One or more in class (such as capric acid) and amide, silicone oil, silicone compound.
Described emulsifying agent is selected from: agriculture breast 500# (alkyl benzene calcium sulfonate), OP series phosphoric acid
Ester (thermally coupled distillation columns), 600# phosphate ester (phenyl phenol polyoxyethyl ether phosphorus
Acid esters), styrene polyoxyethylene ether ammonium sulfate salt, alkyl biphenyl ether disulfonic acid magnesium salt, three second
Alcohol amine salt, agriculture breast 400# (benzyl dimethyl phenol polyoxyethyl ether), agriculture breast 600# (phenyl phenol
Polyoxyethyl ether), Nongru-700 # (alkylphenol-formaldehyde resin polyoxyethyl ether), agriculture breast 36#
(phenethyl fluosite polyoxyethyl ether), agriculture breast 1600# (phenethyl phenol polyoxyethanyl
Polypropylene-base ether), ethylene oxide-propylene oxide block copolymer, OP series (nonyl phenol gather
Oxygen vinyl Ether), By series (castor oil polyoxyethylene ether), agriculture breast 33# (alkylaryl polyoxy
Propylene polyoxyethylene ether), agriculture breast 34# (alkylaryl polyoxyethylene poly-oxygen propylene aether), span
Series (sorbitan monostearate), TWEEN Series (sorbitan fatty acid ester polyoxy
Vinyl Ether), AEO series (fat alcohol polyoxyethylenated alcohol) in one or more.
Described stabilizer selected from sodium sorbate, butyl glycidyl ether, phenyl glycidyl ether,
One or more in cresyl glycidyl ether, polyethylene glycol diglycidyl ether；
Described filler is selected from: Kaolin, kieselguhr, bentonite, attapulgite, white carbon,
One or more in starch, precipitated calcium carbonate.
The compositions of the present invention through dilution or directly can be used before use by user.It is joined
System can be prepared by common processing method, will mix with liquid flux or solid carrier by active substance
After conjunction, add surfactant such as dispersant, stabilizer, wetting agent, binding agent, froth breaking
One or more in agent etc..
The bactericidal composition of the present invention, can be processed on any pesticide acceptable dose on demand
Type.Wherein preferred dosage form is aqueous emulsion, microemulsion, suspending agent or suspension emulsion.
It is an advantage of the current invention that: after (1) volution bacterium amine and active component B compound, have
Notable synergistic and lasting effect；(2) expand fungicidal spectrum, to downy mildew, epidemic disease, anthrax,
The diseases such as powdery mildew, rust, spot defoliation, leaf spot, scab, rice blast all have relatively
High activity；(3) present invention does not use organic solvent, is not likely to produce poisoning, it is simple to transports and stores up
Hide；(4) decrease the dosage of pesticide, reduce pesticide residual quantity on crop, alleviate
Environmental pollution.
Detailed description of the invention
Below in conjunction with embodiment, further instruction of the present invention, the percentage ratio in embodiment are
Ratio of weight and number, but the invention is not limited in this.
The embodiment of the present invention is the method using Toxicity Determination and field test to combine.
Application Example one
Example 1 40% volution bacterium amine kresoxim-methyl aqueous emulsion
Volution bacterium amine 30%, kresoxim-methyl 10%, castor oil polyoxyethylene ether 6%, C3-C6 alcohol
5%, gelatin 0.5%, glycerol 4%, sodium chloride 2%, silicone oil 0.4%, deionized water is mended
Foot 100%, prepares 40% volution bacterium amine kresoxim-methyl aqueous emulsion.
Example 2 48% volution bacterium amine kresoxim-methyl aqueous emulsion
Volution bacterium amine 40%, kresoxim-methyl 8%, phenethyl phenol polyethenoxy ether 7%, alkylbenzene
Sulfonate 5%, C3-C6 alcohol 5%, glycerol 4%, arabic gum 1%, silicone oil 0.4%, go
Ionized water supplies 100%, prepares 48% volution bacterium amine kresoxim-methyl aqueous emulsion.
Example 3 55% volution bacterium amine kresoxim-methyl microemulsion
Volution bacterium amine 50%, kresoxim-methyl 5%, Span series 8%, fatty alcohol-polyoxyethylene ether
Phosphate ester 7%, propylene glycol 3%, gelatin 1%, silicone oil 0.4%, deionized water supplies 100%,
It is mixed to prepare 55% volution bacterium amine kresoxim-methyl microemulsion.
Example 4 45% volution bacterium amine kresoxim-methyl microemulsion
Volution bacterium amine 35%, kresoxim-methyl 10%, tween 4%, alkylbenzenesulfonate 3%, benzene
Ethyl phenol polyoxyethylene ether phosphate 5%, xanthan gum 2%, propylene glycol 3%, silicone oil 0.4%,
Deionized water supplies 100%, is mixed to prepare 45% volution bacterium amine kresoxim-methyl microemulsion.
Example 5 20% volution bacterium amine kresoxim-methyl suspending agent
Volution bacterium amine 10%, kresoxim-methyl 10%, alkyl benzene sulfonate calcium salt 7%, Bombyx mori L. 4%,
C8～10Aliphatic alcohols 0.4%, xanthan gum 0.8%, propylene glycol 2%, deionized water add to 100%,
It is mixed to prepare 20% volution bacterium amine kresoxim-methyl suspending agent.
Example 6 48% volution bacterium amine kresoxim-methyl suspending agent
Volution bacterium amine 8%, kresoxim-methyl 40%, alkylnaphthalene sulfonate 6%, Fructus Sapindi Mukouossi powder 5%,
Silicone 0.2%, polyvinyl alcohol 1%, glycerol 3%, deionized water add to 100%, mixing
Prepare 48% volution bacterium amine kresoxim-methyl suspending agent.
Example 7 20% volution bacterium amine kresoxim-methyl suspension emulsion
Volution bacterium amine 5%, kresoxim-methyl 15%, phenyl phenol polyoxyethanyl ether phosphate 8%, alkane
Base benzenesulfonic acid calcium salt 7%, Bombyx mori L. 4%, C8～10Aliphatic alcohols 0.4%, xanthan gum 0.8%, third
Glycol 2%, deionized water add to 100%, are mixed to prepare 20% volution bacterium amine kresoxim-methyl and hang
Emulsion.
Example 8 48% volution bacterium amine kresoxim-methyl suspension emulsion
Volution bacterium amine 8%, kresoxim-methyl 40%, NPE) 6%, alkylnaphthalene sulphur
Hydrochlorate 6%, Fructus Sapindi Mukouossi powder 5%, silicone 0.2%, polyvinyl alcohol 1%, glycerol 3%,
Deionized water adds to 100%, is mixed to prepare 48% volution bacterium amine kresoxim-methyl suspension emulsion.
Example 9 50% volution bacterium amine ZJ0712 aqueous emulsion
Volution bacterium amine 40%, ZJ0712 10%, alkylbenzenesulfonate 4%, alkyl phenol polyoxy
Vinyl Ether 5%, C3-C6 alcohol 7%, propylene glycol 4%, polyvinyl alcohol 1%, silicone oil 0.4%,
Deionized water supplies 100%, and mixture carries out comminution by gas stream, prepares 50% volution bacterium amine benzene
Kresoxim-methyl aqueous emulsion.
Example 10 40% volution bacterium amine ZJ0712 aqueous emulsion
Volution bacterium amine 38%, ZJ0712 2%, fatty alcohol-polyoxyethylene ether 6%, alkylbenzene
Sulfonate 4%, C3-C6 alcohol 5%, Polyethylene Glycol 2%, gelatin 2%, silicone oil 0.4%, go
Ionized water supplies 100%, prepares 40% volution bacterium amine ZJ0712 aqueous emulsion.
Example 11 40% volution bacterium amine ZJ0712 microemulsion
Volution bacterium amine 10%, ZJ0712 30%, alkylphenol polyoxyethylene phosphate ester 3%,
Castor oil polyoxyethylene ether 5%, gelatin 2%, glycerol 3%, silicone oil 0.4%, deionized water
Supply 100%, be mixed to prepare 40% volution bacterium amine ZJ0712 microemulsion.
Example 12 35% volution bacterium amine ZJ0712 microemulsion
Volution bacterium amine 20%, ZJ0712 15%, ethylene glycol 4%, polyvinyl alcohol 2%, non-
Ion EO-PO block copolymer 8%, alkylbenzenesulfonate 3%, silicone oil 0.4%, deionization
Water supplies 100%, is mixed to prepare 35% volution bacterium amine ZJ0712 microemulsion.
Example 13 30% volution bacterium amine ZJ0712 suspending agent
Volution bacterium amine 15%, ZJ0712 15%, polycarboxylate 6%, wetting and penetrating agent F4%,
Silicone oil 0.6%, arabic gum 0.8%, ethylene glycol 2%, deionized water add to 100%, mixing
Prepare 30% volution bacterium amine ZJ0712 suspending agent.
Example 14 40% volution bacterium amine ZJ0712 suspending agent
Volution bacterium amine 32%, ZJ0712 8%, alkyl benzene sulfonate calcium salt 8%, Fructus Sapindi Mukouossi powder
5%, C10～20Saturated fat acids 1.2%, polyvinylpyrrolidone 1.5%, propylene glycol 3%,
Deionized water adds to 100%, is mixed to prepare 40% volution bacterium amine ZJ0712 suspending agent.
Example 15 30% volution bacterium amine ZJ0712 suspension emulsion
Volution bacterium amine 10%, ZJ0712 20%, castor oil polyoxyethylene ether 7%, polycarboxylic acids
Salt 6%, wetting and penetrating agent F4%, silicone oil 0.6%, arabic gum 0.8%, ethylene glycol 2%,
Deionized water adds to 100%, is mixed to prepare 30% volution bacterium amine ZJ0712 suspension emulsion.
Example 16 40% volution bacterium amine ZJ0712 suspension emulsion
Volution bacterium amine 30%, ZJ0712 10%, fatty alcohol-polyoxyethylene ether 6%, alkylbenzene
Sulfonic acid calcium salt 8%, Fructus Sapindi Mukouossi powder 5%, C10～20Saturated fat acids 1.2%, polyethylene pyrrole
Pyrrolidone 1.5%, propylene glycol 3%, deionized water add to 100%, are mixed to prepare 40% volution
Bacterium amine ZJ0712 suspension emulsion.
Example 17 50% volution bacterium amine pyraclostrobin aqueous emulsion
Volution bacterium amine 40%, pyraclostrobin 10%, fatty alcohol-polyoxyethylene ether 6%, alkyl
Benzene sulfonate 4%, C3-C6 alcohol 5%, Polyethylene Glycol 2%, gelatin 2%, silicone oil 0.4%,
Deionized water supplies 100%, prepares 50% volution bacterium amine pyraclostrobin aqueous emulsion.
Example 18 25% volution bacterium amine pyraclostrobin aqueous emulsion
Volution bacterium amine 20%, pyraclostrobin 5%, alkylbenzenesulfonate 4%, alkyl phenol are poly-
Oxygen vinyl Ether 5%, C3-C6 alcohol 7%, propylene glycol 4%, polyvinyl alcohol 1%, silicone oil 0.4%,
Deionized water supplies 100%, and mixture carries out comminution by gas stream, prepares 25% volution bacterium amine pyrrole
Azoles kresoxim-methyl aqueous emulsion.
Example 19 50% volution bacterium amine pyraclostrobin microemulsion
Volution bacterium amine 10%, pyraclostrobin 40%, tween 4%, alkylbenzenesulfonate 3%,
Phenethyl phenol polyethenoxy ether phosphate 5%, xanthan gum 2%, propylene glycol 3%, silicone oil 0.4%,
Deionized water supplies 100%, is mixed to prepare 50% volution bacterium amine pyraclostrobin microemulsion.
Example 20 35% volution bacterium amine pyraclostrobin microemulsion
Volution bacterium amine 15%, pyraclostrobin 20%, alkylphenol polyoxyethylene phosphate ester 3%,
Castor oil polyoxyethylene ether 5%, gelatin 2%, glycerol 3%, silicone oil 0.4%, deionized water
Supply 100%, be mixed to prepare 35% volution bacterium amine pyraclostrobin microemulsion.
Example 21 32% volution bacterium amine pyraclostrobin suspending agent
Volution bacterium amine 24%, pyraclostrobin 8%, the phonetic formaldehyde condensation products of alkylphenol-polyethenoxy
Sulfate 10%, sodium lauryl sulphate 4%, silicone oil 0.2%, sodium tripolyphosphate 1%, poly-
Ethylene glycol 2%, deionized water add to 100%, are mixed to prepare 32% volution bacterium amine pyrazoles ether
Bacterium ester suspending agent.
Example 22 42% volution bacterium amine pyraclostrobin suspending agent
Volution bacterium amine 20%, pyraclostrobin 22%, polyoxyethylene carboxylate 6%, moistening
Penetrating agent F 6%, silicone compound 1.2%, crospolyvinylpyrrolidone 0.6%, the third two
Alcohol 2%, deionized water add to 100%, are mixed to prepare 42% volution bacterium amine pyraclostrobin
Suspending agent.
Example 23 32% volution bacterium amine pyraclostrobin suspension emulsion
Volution bacterium amine 8%, pyraclostrobin 24%, the phonetic formaldehyde condensation products of alkylphenol-polyethenoxy
Sulfate 10%, castor oil polyoxyethylene ether 5%, sodium lauryl sulphate 4%, silicone oil 0.2%,
Sodium tripolyphosphate 1%, Polyethylene Glycol 2%, deionized water add to 100%, are mixed to prepare 32%
Volution bacterium amine pyraclostrobin suspension emulsion.
Example 24 45% volution bacterium amine pyraclostrobin suspension emulsion
Volution bacterium amine 5%, pyraclostrobin 40%, sorbitan monostearate 4%, fat
Fat acid polyoxyethylene ester 6%, wetting and penetrating agent F 6%, silicone compound 1.2%, crosslinking
Polyvinylpyrrolidone 0.6%, propylene glycol 2%, deionized water add to 100%, are mixed to prepare
45% volution bacterium amine pyraclostrobin suspension emulsion.
Example 25 45% volution bacterium amine Enestroburin aqueous emulsion
Volution bacterium amine 15%, Enestroburin 30%, fatty alcohol-polyoxyethylene ether 6%, alkylbenzene
Sulfonate 4%, C3-C6 alcohol 5%, Polyethylene Glycol 2%, gelatin 2%, silicone oil 0.4%, go
Ionized water supplies 100%, prepares 45% volution bacterium amine Enestroburin aqueous emulsion.
Example 26 30% volution bacterium amine Enestroburin aqueous emulsion
Volution bacterium amine 20%, Enestroburin 10%, alkylbenzenesulfonate 4%, alkyl phenol polyoxy
Vinyl Ether 5%, C3-C6 alcohol 7%, propylene glycol 4%, polyvinyl alcohol 1%, silicone oil 0.4%,
Deionized water supplies 100%, prepares 30% volution bacterium amine Enestroburin aqueous emulsion.
Example 27 36% volution bacterium amine Enestroburin microemulsion
Volution bacterium amine 24%, Enestroburin 12%, Span series 8%, aliphatic alcohol polyethenoxy
Ether phosphate 7%, propylene glycol 3%, gelatin 1%, silicone oil 0.4%, deionized water supplies 100%,
It is mixed to prepare 36% volution bacterium amine Enestroburin microemulsion.
Example 28 42% volution bacterium amine Enestroburin microemulsion
Volution bacterium amine 32%, Enestroburin 10%, ethylene glycol 4%, polyvinyl alcohol 2%, non-
Ion EO-PO block copolymer 8%, alkylbenzenesulfonate 3%, silicone oil 0.4%, deionization
Water supplies 100%, is mixed to prepare 42% volution bacterium amine Enestroburin microemulsion.
Example 29 16% volution bacterium amine Enestroburin suspending agent
Volution bacterium amine 8%, Enestroburin 8%, polycarboxylate 8%, Nekal BX 6%, silicon
Ketone compounds 0.7%, xanthan gum 0.6%, propylene glycol 1%, deionized water add to 100%,
It is mixed to prepare 16% volution bacterium amine Enestroburin suspending agent.
Example 30 42% volution bacterium amine Enestroburin suspending agent
Volution bacterium amine 35%, Enestroburin 7%, lignosulfonates 7%, Fructus Sapindi Mukouossi powder 6,
Silicone oil 0.2%, polyvinyl alcohol 1%, ethylene glycol 1%, deionized water add to 100%, mixing system
Obtain 42% volution bacterium amine Enestroburin suspending agent.
Example 31 10% volution bacterium amine Enestroburin suspension emulsion
Volution bacterium amine 5%, Enestroburin 5%, polycarboxylate 6%, sodium lauryl sulphate 3%,
Spaonin powder 4%, polyvinylpyrrolidone 0.5%, glycerol 2%, silicone compound 0.3%,
TWEEN Series 4%, water add to 100%, are mixed to prepare 10% volution bacterium amine Enestroburin and hang
Emulsion.
Example 32 36% volution bacterium amine Enestroburin suspension emulsion
Volution bacterium amine 10%, Enestroburin 26%, aryl phenol polyoxyethylene succinate sulfonic acid
Salt 6%, sodium lauryl sulphate 3%, Bombyx mori L. 2%, sodium tripolyphosphate 1.2%, ethylene glycol
0.8%, C8～10Aliphatic alcohols 1%, agriculture breast 34#3%, water add to 100%, are mixed to prepare 36%
Volution bacterium amine Enestroburin suspension emulsion.
Example 33 38% volution bacterium amine azoxystrobin water emulsion
Volution bacterium amine 30%, Fluoxastrobin 8%, fatty alcohol-polyoxyethylene ether 6%, benzene sulfonamide
Hydrochlorate 4%, C3-C6 alcohol 5%, Polyethylene Glycol 2%, gelatin 2%, silicone oil 0.4%, go from
Sub-water supplies 100%, prepares 38% volution bacterium amine azoxystrobin water emulsion.
Example 34 40% volution bacterium amine azoxystrobin water emulsion
Volution bacterium amine 35%, Fluoxastrobin 5%, alkylbenzenesulfonate 4%, alkyl phenol polyoxy second
Alkene ether 5%, C3-C6 alcohol 7%, propylene glycol 4%, polyvinyl alcohol 1%, silicone oil 0.4%, go
Ionized water supplies 100%, prepares 40% volution bacterium amine azoxystrobin water emulsion.
Example 35 50% volution bacterium amine azoxystrobin microemulsion
Volution bacterium amine 10%, Fluoxastrobin 40%, tween 4%, alkylbenzenesulfonate 3%, benzene
Ethyl phenol polyoxyethylene ether phosphate 5%, xanthan gum 2%, propylene glycol 3%, silicone oil 0.4%,
Deionized water supplies 100%, is mixed to prepare 50% volution bacterium amine azoxystrobin microemulsion.
Example 36 25% volution bacterium amine azoxystrobin microemulsion
Volution bacterium amine 15%, Fluoxastrobin 10%, alkylphenol polyoxyethylene phosphate ester 3%, castor
Oleum Sesami polyoxyethylene ether 5%, gelatin 2%, glycerol 3%, silicone oil 0.4%, deionized water is mended
Foot 100%, is mixed to prepare 25% volution bacterium amine azoxystrobin microemulsion.
Example 37 32% volution bacterium amine Fluoxastrobin suspending agent
Volution bacterium amine 24%, Fluoxastrobin 8%, alkylphenol-polyethenoxy phonetic formaldehyde condensation products sulphuric acid
Salt 10%, sodium lauryl sulphate 4%, silicone oil 0.2%, sodium tripolyphosphate 1%, poly-second two
Alcohol 2%, deionized water add to 100%, are mixed to prepare 32% volution bacterium amine Fluoxastrobin and suspend
Agent.
Example 38 40% volution bacterium amine Fluoxastrobin suspending agent
Volution bacterium amine 20%, Fluoxastrobin 20%, polyoxyethylene carboxylate 6%, moistening infiltration
Agent F 6%, silicone compound 1.2%, crospolyvinylpyrrolidone 0.6%, propylene glycol
2%, deionized water adds to 100%, is mixed to prepare 40% volution bacterium amine Fluoxastrobin suspending agent.
Example 39 10% volution bacterium amine Fluoxastrobin suspension emulsion
Volution bacterium amine 5%, Fluoxastrobin 5%, polycarboxylate 6%, sodium lauryl sulphate 3%,
Spaonin powder 4%, polyvinylpyrrolidone 0.5%, glycerol 2%, silicone compound 0.3%,
TWEEN Series 4%, water add to 100%, are mixed to prepare the outstanding breast of 10% volution bacterium amine Fluoxastrobin
Agent.
Example 40 36% volution bacterium amine Fluoxastrobin suspension emulsion
Volution bacterium amine 10%, Fluoxastrobin 26%, aryl phenol polyoxyethylene succinate sulfonate
6%, sodium lauryl sulphate 3%, Bombyx mori L. 2%, sodium tripolyphosphate 1.5%, ethylene glycol 0.5%,
C8～10Aliphatic alcohols 1%, agriculture breast 34#3%, water add to 100%, are mixed to prepare 36% volution
Bacterium amine Fluoxastrobin suspension emulsion.
The embodiment of the present invention is the method using Toxicity Determination and field test to combine.
First pass through Toxicity Determination, the potentiation ratio after clear and definite two kinds of medicaments are compounding by a certain percentage
(SR), SR ＜ 0.5 is antagonism, and 0.5≤SR≤1.5 are summation action, and SR ＞ 1.5 is
Potentiation, on this basis, then carries out field test.
(B is selected from Fluoxastrobin, kresoxim-methyl, ZJ0712, pyrrole for volution bacterium amine and active component B
Azoles kresoxim-methyl, the one of Enestroburin) the compounding Toxicity Determination to target.
After prerun determines each medicament effective inhibition concentration scope, each medicament is contained by effective ingredient
Amount sets 5 dosage respectively and processes, if clear water comparison.With reference to " farm-chemical indoor determination is tested
Criterion antibacterial " carry out, use mycelial growth rate method to measure the medicament virulence to target fungus.
Measure colony diameter by decussation method after 72h, calculate each process net growth, mycelial growth
Suppression ratio.
Net growth (mm)=measurement colony diameter-5
Mycelial growth inhibition rate is converted into probit value (y), and liquor strength (μ g/mL) is changed
Become logarithm value (x), try to achieve virulence regression equation (y=a+bx) with method of least square, and thus
Calculate the EC of every kind of medicament50Value.Calculate two medicament different ratio according to Wadley method simultaneously
Synergy ratio (SR), SR ＜ 0.5 is antagonism, and 0.5≤SR≤1.5 are summation action,
SR ＞ 1.5 is potentiation.Computing formula is as follows:
Wherein: a, b are respectively active component volution bacterium amine and B (Fluoxastrobin, kresoxim-methyl, benzene
Kresoxim-methyl, pyraclostrobin, Enestroburin) ratio shared in combination；
A is volution bacterium amine；
B is in Fluoxastrobin, kresoxim-methyl, ZJ0712, pyraclostrobin, Enestroburin
Kind.
Implementation of an application example two volution bacterium amine is compounding with kresoxim-methyl to apple mildew Toxicity Determination.
Test medicine is provided by Shaanxi Welch Crop Protection Co., Ltd..
EXPERIMENTAL DESIGN: determine volution bacterium amine, the former medicine of kresoxim-methyl and the two difference through pilot study
Effective inhibition concentration scope of proportioning mixture.
Toxicity test result
Table 1 volution bacterium amine, kresoxim-methyl and the compounding toxicity test analysis of results table to apple mildew thereof
As shown in Table 1, volution bacterium amine, the kresoxim-methyl EC to apple mildew50It is respectively
8.94mg/L and 1.23mg/L.The virulence of kresoxim-methyl is higher than the virulence of volution bacterium amine.Volution bacterium
Amine and kresoxim-methyl proportioning are when 60:1 to 1:40, and potentiation ratio SR is all higher than 1.5, says
Bright volution bacterium amine and kresoxim-methyl mixture in the range of 60 1 to 1 40 all show potentiation
Effect, especially when the proportioning of the two is at 20:1 to 1:10, potentiation becomes apparent from
Prominent, wherein when volution bacterium amine and kresoxim-methyl weight ratio are 51, potentiation ratio SR is maximum,
Potentiation is the most obvious.
Implementation of an application example three volution bacterium amine is compounding with ZJ0712 to be surveyed powdery mildew of cucumber indoor virulence
Fixed.
Test medicine is provided by Shaanxi Welch Crop Protection Co., Ltd..
EXPERIMENTAL DESIGN: through pilot study determine volution bacterium amine, the former medicine of ZJ0712 and the two not
Effective inhibition concentration scope with proportioning mixture.
Toxicity test result
Table 2 volution bacterium amine, ZJ0712 and the compounding toxicity test analysis of results table to powdery mildew of cucumber thereof
As shown in Table 2, volution bacterium amine, the ZJ0712 EC to powdery mildew of cucumber50It is respectively
8.21mg/L and 0.87mg/L.The virulence of ZJ0712 is higher than the virulence of volution bacterium amine.Volution
Bacterium amine and ZJ0712 proportioning are when 60:1 to 1:40, and potentiation ratio SR is all higher than 1.5,
Illustrate that volution bacterium amine and ZJ0712 mixture in the range of 40 1 to 1 40 all shows
Potentiation, especially when the proportioning of the two is at 20:1 to 1:10, potentiation is more
The most prominent, the wherein potentiation ratio SR when volution bacterium amine and ZJ0712 weight ratio are 51
Maximum, potentiation is the most obvious.
Implementation of an application example four
Volution bacterium amine is compounding with pyraclostrobin to sigatoka Toxicity Determination.
Test medicine is provided by Shaanxi Welch Crop Protection Co., Ltd..
EXPERIMENTAL DESIGN: through pilot study determine volution bacterium amine, the former medicine of pyraclostrobin and the two
Effective inhibition concentration scope of different ratio mixture.
Toxicity test result
Table 3 volution bacterium amine, pyraclostrobin and the compounding toxicity test analysis of results table to wheat rust thereof
As shown in Table 3, volution bacterium amine, the pyraclostrobin EC to wheat rust50It is respectively
8.86mg/L and 1.19mg/L.The virulence of pyraclostrobin is higher than the virulence of volution bacterium amine.Spiral shell
Ring bacterium amine and pyraclostrobin proportioning are when 60:1 to 1:40, and potentiation ratio SR is all higher than
1.5, volution bacterium amine and pyraclostrobin mixture in the range of 40 1 to 1 20 are described
All show potentiation, especially when the proportioning of the two is at 20:1 to 1:10, potentiation
Effect becomes apparent from highlighting, wherein when volution bacterium amine and pyraclostrobin weight ratio are 51
Potentiation ratio SR is maximum, and potentiation is the most obvious.
Implementation of an application example five:
Volution bacterium amine is compounding with Enestroburin to downy mildew of garpe Toxicity Determination.
Test medicine is provided by Shaanxi Welch Crop Protection Co., Ltd..
EXPERIMENTAL DESIGN: through pilot study determine volution bacterium amine, the former medicine of Enestroburin and the two not
Effective inhibition concentration scope with proportioning mixture.
Toxicity test result
Table 4 volution bacterium amine, Enestroburin and the compounding toxicity test analysis of results table to downy mildew of garpe thereof
As shown in Table 4, volution bacterium amine, the Enestroburin EC to downy mildew of garpe50It is respectively
8.85mg/L and 1.07mg/L.The virulence of Enestroburin is higher than the virulence of volution bacterium amine.Volution
Bacterium amine and Enestroburin ratio are when 60:1 to 1:40, and potentiation ratio SR is all higher than 1.5,
Illustrate that volution bacterium amine and Enestroburin mixture in the range of 40 1 to 1 20 all shows
Potentiation, wherein the potentiation ratio SR when volution bacterium amine and Enestroburin weight ratio are 51
Maximum, potentiation is the most obvious.
Implementation of an application example six:
Volution bacterium amine and azoxystrobin compound are to graw mold of tomato Toxicity Determination.
Test medicine is provided by Shaanxi Welch Crop Protection Co., Ltd..
EXPERIMENTAL DESIGN: determine volution bacterium amine, the former medicine of Fluoxastrobin and the two difference through pilot study
Effective inhibition concentration scope of proportioning mixture.
Toxicity test result
Table 5 volution bacterium amine, Fluoxastrobin and the compounding toxicity test analysis of results table to graw mold of tomato thereof
As shown in Table 5, volution bacterium amine, the Fluoxastrobin EC to graw mold of tomato50It is respectively
8.34mg/L and 1.25mg/L.The virulence of Fluoxastrobin is higher than the virulence of volution bacterium amine.Volution bacterium
Amine and Fluoxastrobin ratio are when 60:1 to 1:40, and potentiation ratio SR is all higher than 1.5, explanation
Volution bacterium amine and Fluoxastrobin mixture in the range of 40 1 to 1 20 all show potentiation and make
With, wherein when volution bacterium amine and Fluoxastrobin weight ratio are 51, potentiation ratio SR is maximum,
Potentiation is the most obvious.
Application Example seven volution bacterium amine and kresoxim-methyl and compounding prevent and treat the apple mildew test of pesticide effectiveness
This experimental establishment is in Liquan County, Xianyang, Shanxi province city, and test medicine is by Shaanxi Wei Erqi crop
Protection company limited research and development, provide, comparison medicament 50% volution bacterium amine cream (commercial), 30%
Kresoxim-methyl wettable powder (commercial).
Apple mildew disease index is investigated, in their early stage dispenser, after 10 days second before medicine
Secondary dispenser, altogether dispenser 3 times, investigate disease indexs and count for after dispenser 7 days, 21 days for the second time
Calculate preventive effect.Experimental result is as follows:
Table 6 volution bacterium amine, kresoxim-methyl and compounding prevent and treat the apple mildew test of pesticide effectiveness
As can be seen from Table 6, Fructus Mali pumilae white lead can effectively be prevented and treated after volution bacterium amine is compounding with kresoxim-methyl
Disease, prevention effect is superior to the preventive effect of single dose.In test scope of medication to target crop invariably
Good impact.
Application Example eight volution bacterium amine and ZJ0712 and compounding prevent and treat wheat rust medicine
Effect test
This experimental establishment is in suburb, Rizhao City, Shandong Province, and test medicine is protected by Shaanxi Wei Erqi crop
Protect company limited research and development, provide, comparison medicament 50% volution bacterium amine cream (commercial), 10%
ZJ0712 suspending agent (commercial).
The wheat rust state of an illness is investigated, in the dispenser for the first time of state of an illness initial stage, dispenser one in every 7 days before medicine
Secondary, dispenser 2 times altogether.Within after dispenser 7 days, 21 days for the second time, investigate disease index respectively and count
Calculate preventive effect.Experimental result is as follows:
Table 7 volution bacterium amine, ZJ0712 and compounding prevent and treat the wheat rust test of pesticide effectiveness
As can be seen from Table 7, Semen Tritici aestivi rust can effectively be prevented and treated after volution bacterium amine is compounding with ZJ0712
Disease, prevention effect is superior to the preventive effect of single dose.In test scope of medication to target crop invariably
Good impact.
Application Example nine volution bacterium amine and pyraclostrobin and compounding prevent and treat sigatoka medicine
Effect test
This experimental establishment is in Longan County, Guangxi province Nanning City, and test medicine is by Shaanxi Wei Erqi crop
Protection company limited provides, comparison medicament 50% volution bacterium amine cream (commercial), 250 grams per liters
Pyraclostrobin cream (commercial).
The sigatoka state of an illness is investigated, in the dispenser for the first time of state of an illness initial stage, dispenser in every 7 days before medicine
Once, dispenser 3 times altogether.Within after last dispenser 7 days, 21 days, investigate disease index respectively and count
Calculate preventive effect.Experimental result is as follows:
Table 8 volution bacterium amine, pyraclostrobin and compounding prevent and treat the sigatoka test of pesticide effectiveness
As can be seen from Table 8, Fructus Musae can effectively be prevented and treated after volution bacterium amine is compounding with pyraclostrobin
Leaf spot, prevention effect is superior to the preventive effect of single dose.To target crop in test scope of medication
Have no adverse effects.
Application Example ten volution bacterium amine and Enestroburin and compounding prevent and treat downy mildew of garpe drug effect
Test
This experimental establishment is in Hu County, Shaanxi Province, and test medicine is limited by Shaanxi Wei Erqi crop protection
Company's research and development, offer, comparison medicament 50% volution bacterium amine cream (commercial), 25% alkene oxime bacterium
Emulsifiable concentrate (commercial).
Downy mildew of garpe disease index is investigated, in their early stage dispenser, after 10 days second before medicine
Secondary dispenser, altogether dispenser 2 times, investigate disease indexs and count for after dispenser 7 days, 14 days for the second time
Calculate preventive effect.Experimental result is as follows:
Table 9 volution bacterium amine, Enestroburin and compounding prevent and treat the downy mildew of garpe test of pesticide effectiveness
As can be seen from Table 9, oenin can effectively be prevented and treated after volution bacterium amine is compounding with Enestroburin
Mildew, prevention effect is superior to the preventive effect of single dose.Test scope of medication in target crop without
Harmful effect.
Application Example 11 volution bacterium amine and Fluoxastrobin and compounding preventing and treating wheat powdery mildew drug effect thereof
Test
This experimental establishment is in Fuping County, Shaanxi Province, and test medicine is had by Shaanxi Wei Erqi crop protection
The research and development of limit company, offer, comparison medicament 50% volution bacterium amine cream (commercial), 25% phonetic bacterium
Ester suspending agent (commercial).
Wheat powdery mildew disease index is investigated, in their early stage dispenser, after 10 days second before medicine
Secondary dispenser, altogether dispenser 2 times, investigate disease indexs and count for after dispenser 7 days, 14 days for the second time
Calculate preventive effect.Experimental result is as follows:
Table 10 volution bacterium amine, Fluoxastrobin and the compounding preventing and treating wheat powdery mildew test of pesticide effectiveness thereof
As can be seen from Table 10, white wheat can effectively be prevented and treated after volution bacterium amine and azoxystrobin compound
Powder is sick, and prevention effect is superior to the preventive effect of single dose.Test scope of medication in target crop without
Harmful effect.
Claims (4)
1. the bactericidal composition containing volution bacterium amine with methoxy acrylic, including effective active component, auxiliary agent and filler, it is characterised in that: described effective active composition is A and B, and A, B ratio of weight and number is 4:1 ~ 1:8, described A is volution bacterium amine, and B is pyraclostrobin.
Bactericidal composition containing volution bacterium amine Yu methoxy acrylic the most according to claim 1, it is characterised in that: wherein effective active composition accounts for the 5% ~ 85% of gross weight.
Bactericidal composition containing volution bacterium amine Yu methoxy acrylic the most according to claim 1, it is characterised in that: compositions makes aqueous emulsion, microemulsion, suspending agent or suspension emulsion.
Application containing volution bacterium amine Yu the bactericidal composition of methoxy acrylic the most according to claim 1, it is characterised in that: described compositions is used for preventing and treating downy mildew, epidemic disease, anthrax, powdery mildew, rust, spot defoliation, leaf spot, scab, rice blast.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410404431.4A CN104145973B (en) | 2011-04-26 | 2011-04-26 | A kind of bactericidal composition containing volution bacterium amine Yu methoxy acrylic |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110105521.XA CN102308824B (en) | 2011-04-26 | 2011-04-26 | Bactericide composition containing spiroxamine and methoxyl acrylate |
| CN201410404431.4A CN104145973B (en) | 2011-04-26 | 2011-04-26 | A kind of bactericidal composition containing volution bacterium amine Yu methoxy acrylic |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201110105521.XA Division CN102308824B (en) | 2011-04-26 | 2011-04-26 | Bactericide composition containing spiroxamine and methoxyl acrylate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104145973A CN104145973A (en) | 2014-11-19 |
| CN104145973B true CN104145973B (en) | 2016-08-24 |
Family
ID=51871780
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410404431.4A Active CN104145973B (en) | 2011-04-26 | 2011-04-26 | A kind of bactericidal composition containing volution bacterium amine Yu methoxy acrylic |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104145973B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106106518A (en) * | 2016-06-22 | 2016-11-16 | 殷佩琼 | A kind of compositions preventing and treating orange caterpillar and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1099552A (en) * | 1993-06-02 | 1995-03-08 | 拜尔公司 | Fungicidal compositions |
| CN1154692A (en) * | 1994-07-06 | 1997-07-16 | 巴斯福股份公司 | 2-[(dihydro) pyrazolyl-3'-oxymethyene]-anilides, prepn. method and use thereof |
| CN101822251A (en) * | 2010-01-27 | 2010-09-08 | 深圳诺普信农化股份有限公司 | Sterilization compound containing ZJ0712 |
-
2011
- 2011-04-26 CN CN201410404431.4A patent/CN104145973B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1099552A (en) * | 1993-06-02 | 1995-03-08 | 拜尔公司 | Fungicidal compositions |
| CN1154692A (en) * | 1994-07-06 | 1997-07-16 | 巴斯福股份公司 | 2-[(dihydro) pyrazolyl-3'-oxymethyene]-anilides, prepn. method and use thereof |
| CN101822251A (en) * | 2010-01-27 | 2010-09-08 | 深圳诺普信农化股份有限公司 | Sterilization compound containing ZJ0712 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104145973A (en) | 2014-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102017955A (en) | Bactericidal composite containing metconazole and methoxy acrylate compounds | |
| CN102308824B (en) | Bactericide composition containing spiroxamine and methoxyl acrylate | |
| CN101990895B (en) | Germicidal composition of mandipropamid | |
| CN104145973B (en) | A kind of bactericidal composition containing volution bacterium amine Yu methoxy acrylic | |
| CN102461501A (en) | Bactericidal composition containing mandipropamid and cyazofamid | |
| CN101822264B (en) | Bactericidal composition with pyriproxyfen and thiophanate-methyl | |
| CN102057913B (en) | Bactericidal composition containing triflumizole and triazole compound | |
| CN102047890B (en) | Sterilization composition containing Azoxystrobin and Epoxiconazole | |
| CN101999362B (en) | Fenoxanil and epoxiconazole-containing bactericidal composition | |
| CN103371188B (en) | A kind of Synergistic bactericidal composition containing antibiotic in pyrimidine nucleoside class | |
| CN102239879B (en) | Bactericidal composition containing trifloxystrobin | |
| CN104145974A (en) | Sterilization composition containing spiroxamine and methoxy acrylate | |
| CN101971813B (en) | Sterilization composition containing mandipropamid and azoxystrobin | |
| CN102165957B (en) | Synergic sterilizing composite containing fenbuconazole and triazole compound | |
| CN105685032A (en) | Synergism sterilizing composition containing fenhexamid | |
| CN103314989B (en) | A kind of bactericidal composition containing fenhexamid Yu triazole class compounds | |
| CN102461526A (en) | Germicide composition containing mandipropamid | |
| CN105746531B (en) | A kind of bactericidal composition containing hexaconazole and sym-closene | |
| CN102150673B (en) | Captan-containing bactericidal composition | |
| CN101822265B (en) | Bactericidal composition with probenazole and thiophanate-methyl | |
| CN102461500A (en) | Bactericidal composition containing mandipropamid | |
| CN105766932B (en) | A kind of bactericidal composition of containing trifloxystrobin and sym-closene | |
| CN101971828B (en) | Germicide composition containing kresoxim-methyl and pyrimorph | |
| CN102919242B (en) | Tridemorph-containing sterilizing composition | |
| CN103918671A (en) | Bactericidal composition containing pyrimorph and epoxiconazole |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CP01 | Change in the name or title of a patent holder | ||
| CP01 | Change in the name or title of a patent holder |
Address after: 715500 Pucheng Shaanxi chemical base industrial park, Shaanxi, Weinan Patentee after: Shaanxi yitianfeng crop Technology Co.,Ltd. Address before: 715500 Pucheng Shaanxi chemical base industrial park, Shaanxi, Weinan Patentee before: Shaanxi Welch Crop Protection Co.,Ltd. |
|
| OL01 | Intention to license declared | ||
| OL01 | Intention to license declared |